Related Experiment Video

Updated: Jun 5, 2026

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion
09:23

Impedance-based Real-time Measurement of Cancer Cell Migration and Invasion

Published on: April 2, 2020

Signalling to cancer cell invasion through PAK family kinases

Andrew Whale1, Fariesha Nur Hashim, Sally Fram

  • 1Randall Division of Cell and Molecular Biophysics, King's College London, London.

Frontiers in Bioscience (Landmark Edition)
|January 4, 2011
PubMed

Insights

Rho GTPases regulate cancer cell metastasis. This review highlights the role of p-21 activated kinases (PAKs), downstream effectors of Rac and Cdc42, in driving cancer cell migration and invasion.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Signaling

Background:

  • Cancer cell metastasis is a complex process involving invasion, migration, and colonization.
  • Rho family GTPases (Rho, Rac, Cdc42) are key regulators of metastatic processes.
  • p-21 activated kinases (PAKs) are downstream effectors of Rac and Cdc42, crucial for cell migration and invasion.

Purpose of the Study:

  • To review the latest evidence on the role of PAK family kinases in cancer cell migration and invasion.
  • To elucidate the involvement of PAKs in the signaling pathways driving metastasis.

Main Methods:

  • Literature review focusing on recent research findings.
  • Analysis of the regulatory mechanisms and functions of PAK family kinases (PAK1-6).

Main Results:

  • PAKs are critical mediators of cell migration and invasion in cancer.
  • Group I (PAK1-3) and Group II (PAK4-6) PAKs exhibit distinct regulatory differences, suggesting diverse cellular functions.
  • PAKs integrate signals from Rho GTPases to control cytoskeleton dynamics essential for metastasis.

Conclusions:

  • PAK family kinases are pivotal in the signaling networks that promote cancer cell metastasis.
  • Targeting PAKs may offer therapeutic strategies to inhibit cancer cell migration and invasion.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...